Shares of Strides Arcolab will remain in focus on Thursday as it made a series of "strategic investments” in Oncobiologics Inc, a privately-held New Jersey based firm. The investment is part of Strides’ strategy to fund promising biopharma companies with high quality scientific management and proprietary approaches to developments that confer significant time and cost advantages, a statement released post-market hours said. Financials of the investments were not disclosed in the statement.

comment COMMENT NOW